Evidencia clnica El programa de estudios SURPASS ha sido fundamental para establecer el perfil clnico de tirzepatida, el primer agonista dual GLP-1/GIP aprobado para la DM2
Ulrich R, Clret L, Comstock RD, Kanayama G, Simon P, Pope HG
These results are observed both in clinical trials and in the clinical setting, where tirzepatide for weight loss has shown superior outcomes compared to semaglutide in real-world healthcare environments
Avoid stimulant laxatives (senna, bisacodyl) unless approved by your prescribing provider, as chronic use can reduce your colon's natural contractility
The popularity of semaglutide has exploded on various social media platforms like Facebook, YouTube, Instagram, and TikTok, where people share their weight loss and sugar control journeys
Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC , KC EMC , KCs , KCs for explosion safety products , KGS factory registration and MFDS for medical devices